Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Design Therapeutics

Request full access

Developing a new class of therapies for serious degenerative disorders

Carlsbad, United StatesFounded 2017Biotech & Life Sciences

About Design Therapeutics

DesignTx is a biopharmaceutical company focused on developing novel small molecule therapeutic candidates aimed at providing functional cures for serious genetic diseases with long-standing unmet needs. Operating within the biopharmaceutical sector, DesignTx leverages its Gene Targeted Chimera platform to harness the power of small molecules and deep understanding of gene regulation. The company's target clients include patients suffering from debilitating genetic disorders, healthcare providers, and research institutions. DesignTx's business model revolves around the research, development, and commercialization of its therapeutic candidates. Revenue is generated through the sale of these therapies, partnerships, and potential licensing agreements. The company is driven by a team of global leaders in DNA-targeted small molecules, transcription modulation, and medicinal chemistry, ensuring a robust pipeline of innovative treatments.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Carlsbad, United States
Employees
67
Open positions
None listed
Dealroom signal
77.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Mar 2021 $276M $276M Undisclosed —
SERIES BOther financing Jan 2021 $125M $500M Wellington Management · BlackRock · SR One · Citadel —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMargin
2026 — —
2025 — —
2024 — —
2023 — —
2022 — —
2021 — —
2020 — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Design Therapeutics website traffic

Latest recorded traffic for Design Therapeutics is 4.5K monthly website visits, up 28.6% over the last three months. Design Therapeutics's team grew 6.3% over the past year.

Latest monthly visits4.5K 3-month web change+28.6% 1-year team growth+6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Design Therapeutics in the Carlsbad ecosystem

Live from Dealroom

The Design Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A13 investors entered at this stage

Other known investors1 additional known investor

  • University of Wisconsin-Madison
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Design Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Design Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.